Literature DB >> 10899038

Diacylglycerol and fatty acids synergistically increase cardiomyocyte contraction via activation of PKC.

Y Pi1, J W Walker.   

Abstract

Lipid signaling pathways are thought to play a prominent role in transducing extracellular signals into contractile responses in cardiac muscle. Two putative lipid messengers, diacyglycerol and arachidonic acid, can be generated via distinct phospholipases in separate signaling pathways, but certain stimuli cause them to be elevated in parallel. We tested the hypothesis that these lipids function as comessengers in ventricular myocytes by activating protein kinase C (PKC). In previous work, we demonstrated that the diacylglycerol analog dioctanoylglycerol (diC(8)) can be stimulatory or inhibitory toward myocyte twitches depending on how it is applied. Here we report that arachidonic acid and other cis-unsaturated fatty acids (UFA), at concentrations too low for direct effects, synergistically enhance the stimulatory effects of diC(8) and convert inhibitory effects of diC(8) into stimulation of myocyte twitches. Intracellular Ca(2+) transients changed in parallel with twitch amplitude, suggesting regulation of Ca(2+) homeostasis by these lipids. cis-UFA also interacted synergistically with the PKC activator phorbol 12-myristate 13-acetate to promote positive inotropic responses. Responses were blocked by the PKC antagonists chelerythrine chloride, bisindolylmaleimide, and Gö-6976. DiC(8) and arachidonic acid also synergistically translocated PKC-epsilon and PKC-alpha in intact myocytes. We propose that PKC integrates diacylglycerol and cis-UFA signals in the heart, resulting in preferential activation of positive inotropic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899038     DOI: 10.1152/ajpheart.2000.279.1.H26

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.

Authors:  Neil A Roberts; Robert S Haworth; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

2.  Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A.

Authors:  Aaron C Hinken; Laurin M Hanft; Sarah B Scruggs; Sakthivel Sadayappan; Jeffery Robbins; R John Solaro; Kerry S McDonald
Journal:  J Muscle Res Cell Motil       Date:  2012-04-22       Impact factor: 2.698

3.  Propofol modulates agonist-induced transient receptor potential vanilloid subtype-1 receptor desensitization via a protein kinase Cepsilon-dependent pathway in mouse dorsal root ganglion sensory neurons.

Authors:  Peter J Wickley; Ryo Yuge; Mary S Russell; Hongyu Zhang; Michael A Sulak; Derek S Damron
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

4.  A systems genetics approach identifies Trp53inp2 as a link between cardiomyocyte glucose utilization and hypertrophic response.

Authors:  Marcus M Seldin; Eric D Kim; Milagros C Romay; Shen Li; Christoph D Rau; Jessica J Wang; Karthickeyan Chella Krishnan; Yibin Wang; Arjun Deb; Aldons J Lusis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-24       Impact factor: 4.733

Review 5.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

6.  Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ.

Authors:  Ying-Hsi Lin; Chad M Warren; Jieli Li; Timothy A McKinsey; Brenda Russell
Journal:  Cell Signal       Date:  2016-05-13       Impact factor: 4.315

7.  Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.

Authors:  YeQing Pi; Dahua Zhang; Kara R Kemnitz; Hao Wang; Jeffery W Walker
Journal:  J Physiol       Date:  2003-08-15       Impact factor: 5.182

8.  Mitochondrial involvement in IGF-1 induced protection of cardiomyocytes against hypoxia/reoxygenation injury.

Authors:  YeQing Pi; Michael J Goldenthal; José Marín-García
Journal:  Mol Cell Biochem       Date:  2007-01-31       Impact factor: 3.842

9.  PKC activation by resveratrol derivatives with unsaturated aliphatic chain.

Authors:  Satyabrata Pany; Anjoy Majhi; Joydip Das
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Cluster Differentiating 36 (CD36) Deficiency Attenuates Obesity-Associated Oxidative Stress in the Heart.

Authors:  Mohamed Gharib; Huan Tao; Thomas V Fungwe; Tahar Hajri
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.